Relay Historical Financial Ratios
| RLAY Stock | USD 4.70 0.10 2.08% |
Relay Therapeutics is promptly reporting on over 95 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 6.44, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 3.2 will help investors to properly organize and evaluate Relay Therapeutics financial condition quickly.
Relay |
About Relay Financial Ratios Analysis
Relay TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Relay Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Relay financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Relay Therapeutics history.
Relay Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Relay Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Relay Therapeutics sales, a figure that is much harder to manipulate than other Relay Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Ev To Operating Cash Flow
A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.Most ratios from Relay Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Relay Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relay Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.At this time, Relay Therapeutics' Graham Net Net is fairly stable compared to the past year.
| 2022 | 2023 | 2024 (projected) | Net Debt To EBITDA | 3.07 | 0.24 | 0.23 | Intangibles To Total Assets | 0.002091 | 0.002725 | 0.001893 |
Relay Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Relay Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Relay Stock Analysis
When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.